109 related articles for article (PubMed ID: 7882461)
1. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.
Goppelt-Struebe M; Winter I
Cancer Chemother Pharmacol; 1995; 35(6):519-26. PubMed ID: 7882461
[TBL] [Abstract][Full Text] [Related]
2. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
Wang YZ; Chang YB; Xing C; Fu D
Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
[TBL] [Abstract][Full Text] [Related]
3. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hexadecylphosphocholine with fish oil as an antitumor agent.
Colombo DT; Tran LK; Speck JJ; Reitz RC
J Lipid Mediat Cell Signal; 1997 Sep; 17(1):47-63. PubMed ID: 9302654
[TBL] [Abstract][Full Text] [Related]
5. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
[TBL] [Abstract][Full Text] [Related]
6. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
7. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
8. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells.
Berkovic D; Grunwald U; Menzel W; Unger C; Hiddemann W; Fleer EA
Eur J Cancer; 1995 Nov; 31A(12):2080-5. PubMed ID: 8562169
[TBL] [Abstract][Full Text] [Related]
9. Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy.
Henke J; Engelmann J; Kutscher B; Nssner G; Engel J; Voegeli R; Leibfritz D
Anticancer Res; 1999; 19(5B):4027-32. PubMed ID: 10628349
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
[TBL] [Abstract][Full Text] [Related]
11. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells.
Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
Eur J Biochem; 2002 Sep; 269(18):4649-55. PubMed ID: 12230578
[TBL] [Abstract][Full Text] [Related]
12. Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells.
Berkovic D; Sievers S; Haase D; Fleer EA; Binder C
J Exp Ther Oncol; 2002; 2(2):85-92. PubMed ID: 12415624
[TBL] [Abstract][Full Text] [Related]
13. Investigations on the cellular uptake of hexadecylphosphocholine.
Fleer EA; Berkovic D; Eibl H; Unger C
Lipids; 1993 Aug; 28(8):731-6. PubMed ID: 8377589
[TBL] [Abstract][Full Text] [Related]
14. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
15. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
Bishop FE; Dive C; Freeman S; Gescher A
Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
[TBL] [Abstract][Full Text] [Related]
16. Cellular transport and lipid interactions of miltefosine.
Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
[TBL] [Abstract][Full Text] [Related]
17. Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays.
Schaider H; Seidl H; Berger MR; Hofmann-Wellenhof R; Tritthart HA; Smolle J
Anticancer Res; 1998; 18(2A):995-8. PubMed ID: 9615753
[TBL] [Abstract][Full Text] [Related]
18. Effects of hexadecylphosphocholine on thrombocytopoiesis.
Berkovic D; Bensch M; Bertram J; Wille T; Haase D; Binder C; Fleer EA
Eur J Cancer; 2001 Mar; 37(4):503-11. PubMed ID: 11267861
[TBL] [Abstract][Full Text] [Related]
19. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.
Wieder T; Orfanos CE; Geilen CC
J Biol Chem; 1998 May; 273(18):11025-31. PubMed ID: 9556584
[TBL] [Abstract][Full Text] [Related]
20. The effect of hexadecylphosphocholine on the degradation of mitochondrial phospholipids.
Vagina O; Gellerich FN; Ulbrich-Hofmann R
Mol Cell Biochem; 1998 Jun; 183(1-2):169-73. PubMed ID: 9655193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
